The role of dynamin-related protein 1 in cerebral ischemia/hypoxia injury

Biomed Pharmacother. 2023 Sep:165:115247. doi: 10.1016/j.biopha.2023.115247. Epub 2023 Jul 27.

Abstract

Mitochondrial dysfunction, especially in terms of mitochondrial dynamics, has been reported to be closely associated with neuronal outcomes and neurological impairment in cerebral ischemia/hypoxia injury. Dynamin-related protein 1 (Drp1) is a cytoplasmic GTPase that mediates mitochondrial fission and participates in neuronal cell death, calcium signaling, and oxidative stress. The neuroprotective role of Drp1 inhibition has been confirmed in several central nervous system disease models, demonstrating that targeting Drp1 may shed light on novel approaches for the treatment of cerebral ischemia/hypoxia injury. In this review, we aimed to highlight the roles of Drp1 in programmed cell death, oxidative stress, mitophagy, and mitochondrial function to provide a better understanding of mitochondrial disturbances in cerebral ischemia/hypoxia injury, and we also summarize the advances in novel chemical compounds targeting Drp1 to provide new insights into potential therapies for cerebral ischemia/hypoxia injury.

Keywords: Cerebral ischemia-hypoxia injury; Drp1; Mitochondrial fission; Post-translational modification.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain Ischemia* / drug therapy
  • Brain Ischemia* / metabolism
  • Dynamins / metabolism
  • Humans
  • Hypoxia / metabolism
  • Mitochondria / metabolism
  • Neurons* / metabolism

Substances

  • Dynamins